Market News AIOpen the app

IMCR stock news · Immunocore Holdings plc

Stories about Immunocore Holdings plc (IMCR) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for IMCR

Follow Immunocore Holdings plc (IMCR) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for IMCR
Free on the App Store and Google Play, or on the web.
  1. Nov 6, 2026, 9:09 AM ET · Market

    Immunocore Holdings shared its financial results for the third quarter of 2026 and other company updates.

    Neutral

    Immunocore's 8-K says a press release announced third-quarter results and other updates, but gives no figures. The supplied text does not change the company's outlook.

  2. Oct 23, 2026, 12:41 PM ET · Market

    Morgan Stanley says to keep your shares in Immunocore Holdings plc for now.

    Neutral

    Morgan Stanley kept its rating and $43 share-price target for Immunocore unchanged. The report brings no new company news, so it does not change the company's outlook.

  3. Oct 5, 2026, 9:15 AM ET · Results

    Immunocore Hldgs shares details from their earnings call for the second quarter of 2026.

    Good for IMCR

    Immunocore's Kimmtrak sales grew in the first half, and cash reserves and advancing trials support a stronger outlook despite slower expected growth and a Q3 inventory dip.